REQUEST A DEMO
Total
USD $0.00
Search more companies

Synthon, S.R.O. (Czech Republic)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Synthon, S.R.O. Profile Updated: November 19, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Synthon is a manufacturer of complex generic pharmaceuticals. The company claims to have a commercial presence in various regions, including the MENA region and Mexico. Synthon is also involved in biopharmaceutical research and development, focusing on creating precision medicines for patients with cancers and autoimmune diseases. The company operates a fully integrated site for active pharmaceutical ingredients in the Czech Republic and has completed bioequivalence studies.

Headquarters
Brnenska 597/32
Blansko; Jihomoravsky; Postal Code: 67801

Contact Details: Purchase the Synthon, S.R.O. report to view the information.

Website: http://www.synthon.com

Basic Information
Total Employees:
Purchase the Synthon, S.R.O. report to view the information.
Outstanding Shares:
Purchase the Synthon, S.R.O. report to view the information.
Registered Capital:
Purchase the Synthon, S.R.O. report to view the information.
Incorporation Date:
February 28, 2000
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
CHEMIE BRNO, spol. s r.o.
80%
Company Performance
Financial values in the chart are available after Synthon, S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Total operating revenue
24.88%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?